((自动化翻译由路透提供，请见免责声明 ))
10月4日 - ** CVS Health Corp 股价上涨3.1%，创近五个月新高64.87美元。
** 券商TD Cowen将股票评级从 "持有 "上调至 "买入"，并将目标价从59美元上调至85美元--较上一交易日收盘价上涨35%。
** 券商援引其内部分析称，由于 2025 年其顶级医疗保险优势计划的会员人数有望增长，且福利较低，券商有信心 CVS 在 2025 年实现两位数的每股收益增长。
** 竞争对手Humana 周三股价暴跌， (link)，此前该公司称其顶级医疗保险计划的注册人数大幅下降。
** 分析师平均将 CVS 和同行 Cigna 评为 "买入"，将 HUM 评为 "持有"。
** CVS 年内下跌约 18%，而 HUM 下跌 46.5%，CI 年内上涨约 14
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.